RCKT · Rocket Pharmaceuticals, Inc.

$3.47 +0.13 (+3.89%) At close · Aug 14

Market Cap

$380.92M

109.77M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established	Last Amended	Capacity	Sold	Remaining	Runs Through	Source
2026-03-10	—	$100,000,000	—	—	—	10-Q , filed 2026-05-07

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2021-12-31	$0	—	—	10-K, filed 2022-02-28
2020-12-31	$72,000	—	—	10-K, filed 2022-02-28

2019-12-31	$0	—	—	10-K, filed 2022-02-28
2018-12-31	$0	—	—	10-K, filed 2021-03-01
2017-12-31	$0	—	—	10-K, filed 2019-03-08
2016-12-31	$0	—	—	10-K, filed 2019-03-08

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2021-12-31	$0 Δ	—	—	10-K, filed 2022-02-28
2021-09-30	$0 Δ	—	—	10-Q, filed 2021-11-05
2021-06-30	$0 Δ	—	—	10-Q, filed 2021-08-09
2021-03-31	$0	—	—	10-Q, filed 2021-05-10
2020-12-31	$0 Δ	—	—	10-K, filed 2022-02-28
2020-09-30	$0 Δ	—	—	10-Q, filed 2021-11-05
2020-06-30	$0 Δ	—	—	10-Q, filed 2021-08-09
2020-03-31	$72,000	—	—	10-Q, filed 2021-05-10
2019-09-30	$0 Δ	—	—	10-Q, filed 2020-11-06
2019-06-30	$727,000 Δ	—	—	10-Q, filed 2020-08-05
2019-03-31	$0	—	—	10-Q, filed 2020-05-08
2018-12-31	$0 Δ	—	—	10-K, filed 2021-03-01

Key facts CIK 1281895 CUSIP 77313F106 13F (30d) 178 filings 172 filers Visit website Investor relations